The U.S. FDA is launching a program under which its commissioner can issue vouchers to companies he finds are aligned with ...

Our investigation exposed a little-known practice inside the FDA that allowed more than 150 drugs or their ingredients into ...

The Food and Drug Administration says it will begin offering faster reviews to new medicines that align with Trump ...

The US Food and Drug Administration announced a new national priority voucher plan that aims to cut drug review times to one ...

Food and Drug Administration Commissioner Marty Makary said at a news conference that the agency would take steps to ...

The FDA is launching a program to reward companies with accelerated drug review and speedy agency feedback, if their actions ...

The FDA announced a new fast-track approval program for domestic drug developers for projects that are national priorities.

And offering a fast-track to approve drugs the Trump administration views as a priority. Welcome to the new Food and Drug ...

Eli Lilly will buy Boston-based Verve Therapeutics, Inc. in a billion dollar deal with plans to advance Verve's new line of ...

Capricor Therapeutics has received an orphan drug designation for its drug aimed at potentially treating Becker Muscular Dystrophy. The biotechnology company said Tuesday that the Food and Drug ...